<DOC>
	<DOCNO>NCT00543751</DOCNO>
	<brief_summary>The purpose study compare MK0767 metformin sulfonylurea therapy lower blood glucose patient inadequate glycemic control This early phase trial specific protocol information progress publicly available time . ( Full information available trial participant ) .</brief_summary>
	<brief_title>Placebo Controlled Metformin Sulfonylurea Combination Study Patients With Type 2 Diabetes ( 0767-025 )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Patients Type 2 diabetes wtih inadequate glycemic control maximally effective/tolerated metformin sulfonylurea therapy Nonpregnant females Patients Type 1 Diabetes history ketoacidosis Patients treat insulin antihyperglycemic agent Patients viral hepatitis , active liver gallbladder disease , history pancreatitis , heart disease , congestive heart failure , inadequately control hypertension , HIV positive , history hematologic disorder neoplastic disease</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>78 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>